From: EMT and tumor metastasis
Cancer type | Survival 5-years after cancer has metastasized [ 61 ] | Survival 5-years after diagnosis [ 61 ] | EMT Markers | References |
---|---|---|---|---|
Pancreas | 2.3% | 6.7% | Snail, Twist, Zeb1, Zeb2, E-cadherin, β-catenin Brachyury, HDAC1,2,3, miR-34, miR-200, | |
Liver | 2.8% | 16.6% | Snail, Twist, Zeb1, Zeb2, TGF-β, EZH2, HDAC1,2,3, miR-101, STAT3, SUZ12, | |
Lung | 4.0% | 16.8% | Snail, Zeb1, Zeb2, E-cadherin, vimentin, α-catenin, EZH2, BMI1, Brachyury, Claudin-1, Cytokeratins, G9a, HDAC1,2,3, LSD1, miR-34, miR-101, miR-205, Periostin, Slug, SUZ12, TTF-1, versican, N-cadherin | |
Bladder | 5.5% | 77.4% | Twist, Zeb1, Zeb2, N-cadherin, EZH2, Fibronectin, LSD1, miRs-1/133a/218, miR-19a, miRs-30a-3p/133a/199a, miR-34, miR-99a/100, miR-101, miR-125b, miR-129, miR-145/133a, miR-200, miR-205, miR-221, N- | |
Renal | 12.1% | 72.4% | TGF-β, BMP-7, Claudin-1, HDAC1,2,3, hepatocyte growth factor, Klf8, miR-23b, miR-29b, miR-34, miRs-141/200, miR-205, miR-438-3p, | |
Colorectal | 12.9% | 64.7% | Snail, Twist, vimentin, Zeb1, Zeb2, β-catenin, Brachyury, CD44, E-cadherin, EZH2, FGFR4, Fibronectin, HDAC1,2,3, LSD1, miR-34, p16INK4a, SIRT1, Slug, SUZ12, SUV39H1, | |
Cervical | 16.1% | 67.9% | Snail, Twist, E-cadherin, vimentin, β-catenin, EGFR, | |
Skin melanoma | 16.1% | 91.3% | TGF-β, MITF, N-cadherin, miR-205 | |
Ovarian | 27.4% | 44.6% | Snail, Twist, Zeb1, Zeb2, E-cadherin, CCR7, Claudin-1, Fibronectin, Klf8, miR-9, miR-34, miR-200, N-cadherin, Occludin, PTEN, Slug, STK11, | |
Breast | 25.0% | 89.2% | Snail, Zeb1, Zeb2, vimentin, β-catenin, E-cadherin, BMI1, Brachyury, Claudin, EZH2, HDAC1,2,3, Klf8, LSD1, miR-9 (2); miR-10b, miR-34, Slug, SUZ12, Twist, versican, | |
Prostate | 28.0% | 98.9% | Twist, Zeb1, N-cadherin, APC, Cyclin D2, collagen, decorin, E47, E-cadherin, ER, EZH2, Fibronectin, GSTP1, HDAC1,2,3, Let-7a, LSD1, miR-1, miR-7, miR-15a-16 cluster, miR20a, miR-21, miR-24, miR-32, miR-34a, miR-34c, miR-101, miR-106b, miR-107, miR125b, miR-143, miR-145, miR-146a, miR-148a, miR-205, miR-221, miR-222, miR-331-3P, miR-449a, miR-521, miR-1296, Notch-1, RAR-β2, RASSF1A, versican, | |
Brain/nervous system | 35.6% | 33.4% | miR-9, Klf8 | [62] |